These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 33732633)

  • 41. Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus.
    Mazalovska M; Kouokam JC
    Viruses; 2020 Jul; 12(8):. PubMed ID: 32751441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis B virus-like particles expressing Plasmodium falciparum epitopes induce complement-fixing antibodies against the circumsporozoite protein.
    Kingston NJ; Kurtovic L; Walsh R; Joe C; Lovrecz G; Locarnini S; Beeson JG; Netter HJ
    Vaccine; 2019 Mar; 37(12):1674-1684. PubMed ID: 30773400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Scalable chromatography-based purification of virus-like particle carrier for epitope based influenza A vaccine produced in Escherichia coli.
    Lagoutte P; Mignon C; Donnat S; Stadthagen G; Mast J; Sodoyer R; Lugari A; Werle B
    J Virol Methods; 2016 Jun; 232():8-11. PubMed ID: 26947397
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-effective purification process development for chimeric hepatitis B core (HBc) virus-like particles assisted by molecular dynamic simulation.
    Zhang B; Yin S; Wang Y; Su Z; Bi J
    Eng Life Sci; 2021 Jun; 21(6):438-452. PubMed ID: 34140854
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A DNA replicon system for rapid high-level production of virus-like particles in plants.
    Huang Z; Chen Q; Hjelm B; Arntzen C; Mason H
    Biotechnol Bioeng; 2009 Jul; 103(4):706-14. PubMed ID: 19309755
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunogenicity of Leishmania-derived hepatitis B small surface antigen particles exposing highly conserved E2 epitope of hepatitis C virus.
    Czarnota A; Tyborowska J; Peszyńska-Sularz G; Gromadzka B; Bieńkowska-Szewczyk K; Grzyb K
    Microb Cell Fact; 2016 Apr; 15():62. PubMed ID: 27075377
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccine synergy with virus-like particle and immune complex platforms for delivery of human papillomavirus L2 antigen.
    Diamos AG; Larios D; Brown L; Kilbourne J; Kim HS; Saxena D; Palmer KE; Mason HS
    Vaccine; 2019 Jan; 37(1):137-144. PubMed ID: 30459071
    [TBL] [Abstract][Full Text] [Related]  

  • 49. VelcroVax: a "Bolt-On" Vaccine Platform for Glycoprotein Display.
    Kingston NJ; Grehan K; Snowden JS; Hassall M; Alzahrani J; Paesen GC; Sherry L; Hayward C; Roe A; Stephen S; Tomlinson D; Zeltina A; Doores KJ; Ranson NA; Stacey M; Page M; Rose NJ; Bowden TA; Rowlands DJ; Stonehouse NJ
    mSphere; 2023 Feb; 8(1):e0056822. PubMed ID: 36719225
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biochemical composition of haemagglutinin-based influenza virus-like particle vaccine produced by transient expression in tobacco plants.
    Le Mauff F; Mercier G; Chan P; Burel C; Vaudry D; Bardor M; Vézina LP; Couture M; Lerouge P; Landry N
    Plant Biotechnol J; 2015 Jun; 13(5):717-25. PubMed ID: 25523794
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice.
    Huo C; Yang J; Lei L; Qiao L; Xin J; Pan Z
    Vaccine; 2017 Dec; 35(52):7322-7330. PubMed ID: 29129453
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Virus like particles as a platform for cancer vaccine development.
    Ong HK; Tan WS; Ho KL
    PeerJ; 2017; 5():e4053. PubMed ID: 29158984
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Virus-like particles as vaccine.
    Chroboczek J; Szurgot I; Szolajska E
    Acta Biochim Pol; 2014; 61(3):531-9. PubMed ID: 25273564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Designing Chimeric Virus-like Particle-based Vaccines for Human Papillomavirus and HIV: Lessons Learned.
    Eto Y; Saubi N; Ferrer P; Joseph J
    AIDS Rev; 2019; 21(4):218-232. PubMed ID: 31834327
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deletion modification enhances anthrax specific immunity and protective efficacy of a hepatitis B core particle-based anthrax epitope vaccine.
    Yin Y; Zhang S; Cai C; Zhang J; Dong D; Guo Q; Fu L; Xu J; Chen W
    Immunobiology; 2014 Feb; 219(2):97-103. PubMed ID: 24054942
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Virus-like particles: potential veterinary vaccine immunogens.
    Liu F; Ge S; Li L; Wu X; Liu Z; Wang Z
    Res Vet Sci; 2012 Oct; 93(2):553-9. PubMed ID: 22100244
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles.
    Skrastina D; Petrovskis I; Lieknina I; Bogans J; Renhofa R; Ose V; Dishlers A; Dekhtyar Y; Pumpens P
    PLoS One; 2014; 9(12):e114006. PubMed ID: 25436773
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza.
    D'Aoust MA; Couture MM; Charland N; Trépanier S; Landry N; Ors F; Vézina LP
    Plant Biotechnol J; 2010 Jun; 8(5):607-19. PubMed ID: 20199612
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhanced stability of a chimeric hepatitis B core antigen virus-like-particle (HBcAg-VLP) by a C-terminal linker-hexahistidine-peptide.
    Schumacher J; Bacic T; Staritzbichler R; Daneschdar M; Klamp T; Arnold P; Jägle S; Türeci Ö; Markl J; Sahin U
    J Nanobiotechnology; 2018 Apr; 16(1):39. PubMed ID: 29653575
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A preliminary study on the activation and antigen presentation of hepatitis B virus core protein virus-like particle-pulsed bone marrow-derived dendritic cells.
    Ding FX; Xian X; Guo YJ; Liu Y; Wang Y; Yang F; Wang YZ; Song SX; Wang F; Sun SH
    Mol Biosyst; 2010 Nov; 6(11):2192-9. PubMed ID: 20820487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.